Memorial Sloan Kettering Cancer Center

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1884-01-01

Employees: 10K

Market Cap: -

Website: http://www.mskcc.org

Clinical Trials

A Study of a Comprehensive Prevention Program to Reduce Lymphedema After Axillary Lymph Node Dissection in People with Breast Cancer

Phase 3

Recruiting

Conditions: Lymphedema
Lymphedema of Upper Arm
Breast Carcinoma
Lymphedema Arm
Breast Cancer
Female Breast Cancer

First Posted Date: 2023-11-22

Last Posted Date: 2024-08-28

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 285

Registration Number: NCT06144164

A Study of Cabozantinib and Nivolumab With Radiation Therapy for People With Renal Cell Carcinoma That Has Spread to the Brain

Phase 1

Recruiting

Conditions: Metastatic Renal Cell Carcinoma
Brain Metastases

Interventions: Drug: Cabozantinib
Device: Nivolumab
Radiation: Stereotactic Radiosurgery (SRS)

First Posted Date: 2023-11-15

Last Posted Date: 2024-12-20

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 20

Registration Number: NCT06132945

Locations: 🇺🇸
Memorial Sloan Kettering Westchester (All Protocol Activities), Harrison, New York, United States
🇺🇸
Memorial Sloan Kettering Basking Ridge (All Protocol Activities), Basking Ridge, New Jersey, United States
🇺🇸
Memorial Sloan Kettering Bergen (All Protocol Activities), Montvale, New Jersey, United States

and more 4 locations

A Study of Single Fraction Stereotactic Body Radiation Therapy (SBRT) Guided by Magnetic Resonance Imaging (MRI) in People With Liver Metastasis From Colorectal Cancer

Phase 2

Recruiting

Conditions: Colorectal Cancer
Liver Metastases

Interventions: Radiation: MR Guided Single Fraction Stereotactic Body Radiation Therapy (SBRT)

First Posted Date: 2023-11-14

Last Posted Date: 2024-12-11

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 32

Registration Number: NCT06130280

Locations: 🇺🇸
Memorial Sloan Kettering Monmouth (Limited Protocol Activities), Middletown, New Jersey, United States
🇺🇸
Memorial Sloan Kettering Bergen (Limited Protocol Activities), Montvale, New Jersey, United States
🇺🇸
Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge, New Jersey, United States

and more 4 locations

A Study to Identify Barriers to Cellular Therapies for People with Plasma Cell Disorders

Recruiting

Conditions: Multiple Myeloma

Interventions: Behavioral: Hospital Anxiety and Depression Scale
Other: Lecture on the role of cellular therapies in relapse/refractory multiple myeloma/RRMM
Behavioral: Duke-UNC Functional Social Support Questionnaire
Behavioral: Distress Thermometer
Behavioral: FACT-BMT
Behavioral: Psychosocial Assessments of Candidates for Transplantation

First Posted Date: 2023-11-13

Last Posted Date: 2024-12-10

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 400

Registration Number: NCT06126341

Locations: 🇺🇸
Memorial Sloan Kettering Nassau, Uniondale, New York, United States
🇺🇸
Memorial Sloan Kettering Westchester, West Harrison, New York, United States
🇺🇸
Memorial Sloan Kettering Basking Ridge, Basking Ridge, New Jersey, United States

and more 4 locations

Study Assessing the Effects of Early Psychiatric Referral on Mental Health and Quality of Life in People with Sarcoma

Not Applicable

Recruiting

Conditions: Sarcoma
Bone Sarcoma
Soft Tissue Sarcoma

Interventions: Other: referral to the Memorial Sloan-Kettering Cancer Center (MSK) Department of Psychiatry and Behavioral Sciences.

First Posted Date: 2023-11-13

Last Posted Date: 2024-10-14

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 70

Registration Number: NCT06129903

Locations: 🇺🇸
Memorial Sloan Kettering at Basking Ridge (Limited Protocol Activities), Basking Ridge, New Jersey, United States
🇺🇸
Memorial Sloan Kettering Monmouth (All Protocol Activities), Middletown, New Jersey, United States
🇺🇸
Memorial Sloan Kettering Bergen (Limited Protocol Activities), Montvale, New Jersey, United States

and more 5 locations

A Study of Changes in Ki67 Expression in People With Breast Cancer Receiving Endocrine Therapy Before Surgery

Not Applicable

Recruiting

Conditions: Breast Cancer

Interventions: Procedure: core needle biopsy
Other: blood draw

First Posted Date: 2023-11-13

Last Posted Date: 2024-08-22

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 42

Registration Number: NCT06127979

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York, New York, United States

Study of Near-Infrared Imaging With Indocyanine Green for Detection of Sentinel Lymph Nodes in People With Vulvar Cancer

Not Applicable

Recruiting

Conditions: Vulvar Cancer

Interventions: Procedure: ICG guided sentinel lymph node biopsy

First Posted Date: 2023-11-13

Last Posted Date: 2024-03-26

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 40

Registration Number: NCT06127836

Locations: 🇺🇸
Memorial Sloan Kettering Monmouth (Limited Protocol Activities), Middletown, New Jersey, United States
🇺🇸
Memorial Sloan Kettering Nassau (Limited Protocol Activities), Uniondale, New York, United States
🇺🇸
Memorial Sloan Kettering Westchester (Limited Protocol Activities), Harrison, New York, United States

and more 5 locations

A Study of Pembrolizumab With Trastuzumab and Chemotherapy in People With Esophagogastric Cancer

Phase 2

Recruiting

Conditions: Gastric Adenocarcinoma
HER2 Gene Mutation
Esophageal Cancer

Interventions: Drug: Pembrolizumab
Drug: Trastuzumab
Drug: Oxaliplatin
Drug: Capecitabine

First Posted Date: 2023-11-08

Last Posted Date: 2024-10-23

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 25

Registration Number: NCT06123338

Locations: 🇺🇸
Johns Hopkins University (Data Collection Only), Baltimore, Maryland, United States
🇺🇸
Massachusetts General Hospital (Data Collection Only), Boston, Massachusetts, United States
🇺🇸
Memorial Sloan Kettering Bergen (Limited Protocol Activities), Montvale, New Jersey, United States

and more 6 locations

A Study of Immunotherapy Treatment in People With Sarcoma

Conditions: Sarcoma

First Posted Date: 2023-11-02

Last Posted Date: 2024-10-29

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 250

Registration Number: NCT06113315

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center Suffolk- Commack (All Protocol Activities), Commack, New York, United States
🇺🇸
Memorial Sloan Kettering Nassau (All Protocol Activities), Uniondale, New York, United States
🇺🇸
Memorial Sloan Kettering Bergen (All Protocol Activities), Montvale, New Jersey, United States

and more 4 locations

A Study of Lenvatinib, Pembrolizumab, and Fulvestrant in People With Breast Cancer

Phase 1

Recruiting

Conditions: Metastatic Breast Cancer

Interventions: Drug: Lenvatinib
Drug: Pembrolizuma
Drug: Fulvestrant

First Posted Date: 2023-11-01

Last Posted Date: 2024-11-18

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 43

Registration Number: NCT06110793

Locations: 🇺🇸
Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge, New Jersey, United States
🇺🇸
Memorial Sloan Kettering Bergen (Limited Protocol Activities), Montvale, New Jersey, United States
🇺🇸
Memorial Sloan Kettering Monmouth (Limited Protocol Activities), Middletown, New Jersey, United States

and more 4 locations

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy